Coronary Artery Bypass Surgery Clinical Trial
Official title:
Safety and Efficacy of Remimazolam in Induction and Maintenance of General Anesthesia in OPCAB Surgery
Remimazolam is a novel short-acting benzodiazepine drug that acts on the benzodiazepine binding site of gamma-aminobutryic acid (GABA) A receptor, is metabolized by esterase, and has a context-sensitive half-time of about 6-7 minutes. Looking at some previous studies using Remimazolam, the safety and efficacy as a general anesthetic have been sufficiently proven. In particular, compared to intravenous anesthetic agents such as propofol, the action time of anesthetics is relatively longer, but the frequency of hypotension is low. However, most studies have been conducted on patients of American Society Anesthesiologist (ASA) class I-II, and studies on patients with high severity have not yet been sufficiently secured. Therefore, this study aims to compare the efficacy and safety of Remimazolam as an anesthetic with Sevoflurane in terms of hemodynamics in patients with high severity undergoing OPCAB surgery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05139108 -
TEE Monitoring and the Incidence of Postoperative Acute Kidney Injury in Coronary Artery Bypass Grafting
|
||
| Completed |
NCT04523064 -
POST-CABGDM: Empagliflozin in Perioperative CABG
|
Phase 4 | |
| Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A | |
| Completed |
NCT01467232 -
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing Coronary Artery Bypass Grafting
|
Phase 2 | |
| Completed |
NCT04631809 -
Computed Tomography Coronary Angiography in Patients With a Previous Coronary Artery Bypass Graft Surgery Trial
|
N/A | |
| Completed |
NCT00073580 -
Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
|
Phase 3 | |
| Terminated |
NCT03346278 -
Text Message Intervention to Improve Cardiac Rehab Participation
|
N/A | |
| Completed |
NCT00303641 -
Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients
|
Phase 1 | |
| Completed |
NCT03823521 -
Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™
|
Phase 3 | |
| Terminated |
NCT00789399 -
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
|
N/A | |
| Completed |
NCT02592824 -
Glutamate for Metabolic Intervention in Coronary Surgery II
|
Phase 3 | |
| Not yet recruiting |
NCT05079724 -
Acute Kidney Injury After Cardiac Surgery
|
||
| Withdrawn |
NCT04379947 -
Preoperative Use of Fractional Flow Reserve in CABG Use and Effectiveness of FFR-based CABG in Real-life Practice
|
||
| Terminated |
NCT00858936 -
Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery
|
Phase 2 | |
| Recruiting |
NCT01386229 -
A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery
|
Phase 4 | |
| Completed |
NCT00653042 -
Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA
|
Phase 2 | |
| Completed |
NCT00318227 -
Randomized Trial of a Liberal Versus a Restrictive Transfusion Strategy in Elderly Cardiac Surgery Patients
|
N/A | |
| Completed |
NCT00372671 -
Evaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation Participation
|
Phase 3 | |
| Completed |
NCT00209521 -
Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery
|
Phase 2 | |
| Recruiting |
NCT05411445 -
Study of Role of Blood Microvescicles and Exosomes in Patients With Graft Occlusion After Aortocoronary Bypass Surgery
|